About
Chris Aakre joined Frazier Life Sciences in 2025 with a focus on company creation. He previously served as a Vice President at Frazier portfolio company HilleVax, which he joined as one of its early employees in 2021, and before that was a Principal at Boston Consulting Group leading health care engagements across R&D, business development, and commercial functions in areas including oncology, vaccines, and cell and gene therapy. He holds a Ph.D. in Microbiology from MIT and a B.S. in Biological Sciences from Stanford University.
Invests in
Biotech
Colleagues at Frazier Life Sciences
Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences
Anna H. Chen
Partner at Frazier Life Sciences
Frequently asked questions
- Who is Christopher Aakre?
- Chris Aakre joined Frazier Life Sciences in 2025 with a focus on company creation. He previously served as a Vice President at Frazier portfolio company HilleVax, which he joined as one of its early employees in 2021, and before that was a Principal at Boston Consulting Group leading health care engagements across R&D, business development, and commercial functions in areas including oncology, vaccines, and cell and gene therapy. He holds a Ph.D. in Microbiology from MIT and a B.S. in Biological Sciences from Stanford University.
- Where does Christopher Aakre work?
- Christopher Aakre is Company Creation (joined 2025) at Frazier Life Sciences.
- What does Christopher Aakre invest in?
- Christopher Aakre invests in Biotech.